New weapon against advanced cancers enters human testing

NCT ID NCT02817633

Ongoing Disease control Sponsor: Tesaro, Inc. Source: ClinicalTrials.gov ↗

Summary

This is the first study in people to test a new immunotherapy drug called TSR-022. The main goals are to find a safe dose and see if the drug can help shrink tumors in adults with advanced cancers that have spread. The study will test TSR-022 by itself and combined with other cancer drugs.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Goodyear, Arizona, 85338, United States
GSK Investigational Site

Scottsdale, Arizona, 85258, United States
GSK Investigational Site

Tucson, Arizona, 85704, United States
GSK Investigational Site

Tucson, Arizona, 85711, United States
GSK Investigational Site

Encinitas, California, 92024, United States
GSK Investigational Site

Fountain Valley, California, 92708, United States
GSK Investigational Site

Los Angeles, California, 90024, United States
GSK Investigational Site

Los Angeles, California, 90025, United States
GSK Investigational Site

San Marcos, California, 92069, United States
GSK Investigational Site

Whittier, California, 90606, United States
GSK Investigational Site

Aurora, Colorado, 80012, United States
GSK Investigational Site

Aurora, Colorado, 80045, United States
GSK Investigational Site

Denver, Colorado, 80218, United States
GSK Investigational Site

New Haven, Connecticut, 06511, United States
GSK Investigational Site

Washington D.C., District of Columbia, 20007, United States
GSK Investigational Site

Jacksonville, Florida, 32224, United States
GSK Investigational Site

Miami, Florida, 33140, United States
GSK Investigational Site

Sarasota, Florida, 34232, United States
GSK Investigational Site

Tampa, Florida, 33612, United States
GSK Investigational Site

Atlanta, Georgia, 30322, United States
GSK Investigational Site

Augusta, Georgia, 30912, United States
GSK Investigational Site

Arlington Heights, Illinois, 60005, United States
GSK Investigational Site

Chicago, Illinois, 60637, United States
GSK Investigational Site

Niles, Illinois, 60714, United States
GSK Investigational Site

Iowa City, Iowa, 52242, United States
GSK Investigational Site

Wichita, Kansas, 67214, United States
GSK Investigational Site

Louisville, Kentucky, 40202, United States
GSK Investigational Site

Pikeville, Kentucky, 41501, United States
GSK Investigational Site

Wheaton, Maryland, 20850, United States
GSK Investigational Site

Boston, Massachusetts, 02114, United States
GSK Investigational Site

Detroit, Michigan, 48202, United States
GSK Investigational Site

Rochester, Minnesota, 55905, United States
GSK Investigational Site

Florissant, Missouri, 63031, United States
GSK Investigational Site

St Louis, Missouri, 63110, United States
GSK Investigational Site

St Louis, Missouri, 63129, United States
GSK Investigational Site

St Louis, Missouri, 63141, United States
GSK Investigational Site

Hackensack, New Jersey, 07601, United States
GSK Investigational Site

New York, New York, 10016, United States
GSK Investigational Site

The Bronx, New York, 10461, United States
GSK Investigational Site

Cincinnati, Ohio, 45242, United States
GSK Investigational Site

Cleveland, Ohio, 44106, United States
GSK Investigational Site

Toledo, Ohio, 43623, United States
GSK Investigational Site

Eugene, Oregon, 97401, United States
GSK Investigational Site

Vancouver, Oregon, 97213-2982, United States
GSK Investigational Site

Bethlehem, Pennsylvania, 18015, United States
GSK Investigational Site

Pittsburgh, Pennsylvania, 15232, United States
GSK Investigational Site

Charleston, South Carolina, 29425, United States
GSK Investigational Site

Greenville, South Carolina, 29605, United States
GSK Investigational Site

Nashville, Tennessee, 37203, United States
GSK Investigational Site

Austin, Texas, 78705, United States
GSK Investigational Site

Dallas, Texas, 75246, United States
GSK Investigational Site

Fort Worth, Texas, 76104, United States
GSK Investigational Site

Houston, Texas, 77030, United States
GSK Investigational Site

Longview, Texas, 75601, United States
GSK Investigational Site

McAllen, Texas, 78503-1298, United States
GSK Investigational Site

San Antonio, Texas, 78229, United States
GSK Investigational Site

Temple, Texas, 76508, United States
GSK Investigational Site

Tyler, Texas, 75702, United States
GSK Investigational Site

Fairfax, Virginia, 22031, United States
GSK Investigational Site

Kennewick, Washington, 99336, United States
GSK Investigational Site

Puyallup, Washington, 98373, United States
GSK Investigational Site

Seattle, Washington, 98111, United States
GSK Investigational Site

Tacoma, Washington, 98405, United States
GSK Investigational Site

Madison, Wisconsin, 53792, United States
GSK Investigational Site

Daegu, 42601, South Korea
GSK Investigational Site

Seoul, 02841, South Korea
GSK Investigational Site

Seoul, 03722, South Korea
GSK Investigational Site

Seoul, 06351, South Korea
GSK Investigational Site

Seoul, 7061, South Korea
GSK Investigational Site

Barcelona, 08017, Spain
GSK Investigational Site

Barcelona, 08025, Spain
GSK Investigational Site

Barcelona, 8035, Spain
GSK Investigational Site

Girona, 17007, Spain
GSK Investigational Site

Jerez de la Frontera, 11407, Spain
GSK Investigational Site

L'Hospitalet de Llobrega, 08908, Spain
GSK Investigational Site

Las Palmas de Gran Canar, 35016, Spain
GSK Investigational Site

Madrid, 28027, Spain
GSK Investigational Site

Madrid, 28040, Spain
GSK Investigational Site

Madrid, 28041, Spain
GSK Investigational Site

Madrid, 28046, Spain
GSK Investigational Site

Madrid, 28222, Spain
GSK Investigational Site

Málaga, 29010, Spain
GSK Investigational Site

Palma de Mallorca, 07120, Spain
GSK Investigational Site

Pamplona, 31008, Spain
GSK Investigational Site

Santander, 39008, Spain
GSK Investigational Site

Seville, 41013, Spain
GSK Investigational Site

Valencia, 46010, Spain
GSK Investigational Site

Valencia, 46026, Spain
GSK Investigational Site

Zaragoza, 50009, Spain

Conditions

Explore the condition pages connected to this study.

NEOPLASMS